{"id":69029,"date":"2026-03-13T12:12:34","date_gmt":"2026-03-13T12:12:34","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=69029"},"modified":"2026-10-15T10:33:59","modified_gmt":"2026-10-15T10:33:59","slug":"ss-31-elamipretide","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ja\/product\/ss-31-elamipretide\/","title":{"rendered":"SS-31 (Elamipretide)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">\u30af\u30a4\u30c3\u30af\u30a2\u30f3\u30b5\u30fc \u2014 SS-31\uff08\u30a8\u30e9\u30df\u30d7\u30ec\u30c1\u30c9\uff09\u3068\u306f\u4f55\u3067\u3059\u304b\uff1f<\/h3>\n<p style=\"margin: 0;\"><strong>SS-31<\/strong> \uff08\u5225\u540d\uff1a <strong>Elamipretide<\/strong> \u307e\u305f\u306f <strong>Bendavia<\/strong>\uff09\u306f\u3001\u9078\u629e\u7684\u306b\u7d50\u5408\u3059\u308b\u5408\u6210\u30c6\u30c8\u30e9\u30da\u30d7\u30c1\u30c9\u3067\u3042\u308a <strong>\u30ab\u30eb\u30b8\u30aa\u30ea\u30d4\u30f3<\/strong> on the inner mitochondrial membrane, stabilizing mitochondrial function under stress. Developed by the Szeto-Schiller lab and now in late-stage clinical development by Stealth BioTherapeutics with FDA orphan-drug designation for rare mitochondrial disease. Supplied in 5\u00a0mg to 50\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>MedsBase\u3067\u5f97\u3089\u308c\u308b\u3082\u306e\uff1a<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/ja\/reviews\/\">\u30ab\u30b9\u30bf\u30de\u30fc\u30ec\u30d3\u30e5\u30fc<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 \u3059\u3079\u3066\u306e\u3054\u6ce8\u6587\u306f\u3001\u5f53\u5e97\u306e <a href=\"https:\/\/medsbase.com\/ja\/medsbase-re-shipment-assurance-policy\/\"><strong>\u518d\u767a\u9001\u4fdd\u8a3c\u30dd\u30ea\u30b7\u30fc<\/strong><\/a> \u2014 \u4e07\u304c\u4e00\u300120\u55b6\u696d\u65e5\u4ee5\u5185\u306b\u5546\u54c1\u304c\u5c4a\u304b\u306a\u3044\u5834\u5408\u306f\u3001\u518d\u767a\u9001\u3044\u305f\u3057\u307e\u3059\u3002<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">\u4ed5\u69d8<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">\u8a73\u7d30<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS\u756a\u53f7<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">736992-21-5<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5206\u5b50\u5f0f<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>32<\/sub>H<sub>49<\/sub>N<sub>9<\/sub>O<sub>5<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5206\u5b50\u91cf<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">639.80 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u914d\u5217<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">D-Arg-2\u2032,6\u2032-Dmt-Lys-Phe-NH<sub>2<\/sub> (Bendavia\u3001MTP-131)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5f62\u614b<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u51cd\u7d50\u4e7e\u71e5\u7c89\u672b\uff08\u307e\u305f\u306f\u4f9b\u7d66\u6642\u306e\u5f62\u614b\uff09<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u7d14\u5ea6<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599%\uff08HPLC\u691c\u8a3c\u6e08\u307f\u3001COA\u306f\u3054\u8981\u671b\u306b\u5fdc\u3058\u3066\u63d0\u4f9b\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u4fdd\u7ba1\u65b9\u6cd5<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u51cd\u7d50\u4e7e\u71e5\u54c1\uff1a\u4f7f\u7528\u6642\u5728\u5eab\u306f2\uff5e8\u2103\uff08\u51b7\u8535\uff09\u306b\u4fdd\u7ba1\u3002\u672a\u958b\u5c01\u30d0\u30a4\u30a2\u30eb\u306e\u9577\u671f\u4fdd\u7ba1\u306b\u306f\u221220\u2103\u3002\u518d\u6eb6\u89e3\u5f8c\uff1a2\uff5e8\u2103\u3067\u7d0430\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3002\u5149\u304b\u3089\u4fdd\u8b77\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u518d\u6eb6\u89e3\u6db2\u306e\u51cd\u7d50\u878d\u89e3\u306f\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u6eb6\u89e3\u6027<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u9759\u83cc\u6c34\uff08\u63a8\u5968\uff09\u307e\u305f\u306f\u77ed\u6642\u9593\u4f7f\u7528\u306e\u5834\u5408\u306f\u6ec5\u83cc\u6c34<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>SS-31\uff08\u30a8\u30e9\u30df\u30d7\u30ec\u30c1\u30c9\uff09\u3068\u306f\u4f55\u3067\u3059\u304b\uff1f<\/h2>\n<p><strong>SS-31<\/strong> \u306f\u5408\u6210\u7d30\u80de\u900f\u904e\u6027\u30c6\u30c8\u30e9\u30da\u30d7\u30c1\u30c9\uff08D-Arg-2\u20196\u2032-dimethyl-L-Tyr-L-Lys-L-Phe\u3001\u7565\u79f0 <strong>Szeto-Schiller 31<\/strong>\uff09\u306f\u30011990\u5e74\u4ee3\u3088\u308a\u30b3\u30fc\u30cd\u30eb\u5927\u5b66\u30ef\u30a4\u30eb\u533b\u79d1\u5927\u5b66\u9662\u306eHazel Szeto\u3068Peter Schiller\u306b\u3088\u3063\u3066\u958b\u767a\u3055\u308c\u307e\u3057\u305f\u3002\u307e\u305f\u3001\u533b\u85ac\u54c1\u958b\u767a\u540d\u3068\u3057\u3066\u306f\u3001 <strong>Elamipretide<\/strong> KYC\uff08Know Your Customer\uff09 <strong>Bendavia<\/strong>, \u3001\u81e8\u5e8a\u958b\u767a\u306f <strong>Stealth BioTherapeutics<\/strong>. Unlike most peptides that bind cell-surface receptors, SS-31 is a <strong>\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u6a19\u7684\u85ac\u5264<\/strong> \u7d30\u80de\u819c\u3068\u30aa\u30eb\u30ac\u30cd\u30e9\u819c\u3092\u901a\u904e\u3057\u3066\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u5185\u819c\u306b\u5230\u9054\u3057\u3001\u305d\u3053\u3067\u7d50\u5408\u3059\u308b <strong>\u30ab\u30eb\u30b8\u30aa\u30ea\u30d4\u30f3<\/strong> \u2014 a phospholipid unique to that location. This selective lipid binding underpins its mechanism of action and distinguishes SS-31 from virtually every other peptide. Molecular weight approximately 640\u00a0Da. SS-31 has <strong>FDA\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a<\/strong> for primary mitochondrial myopathy and has been the subject of multiple human clinical trials \u2014 placing it further along the clinical development pipeline than most peptides. It is supplied here as a high-purity lyophilized powder <strong>for clinical studies use only<\/strong> (Stealth&#8217;s clinical product is a separate regulated therapeutic). For deeper mechanism, Szeto lab studies history, and clinical-trial context, see our <a href=\"https:\/\/medsbase.com\/ja\/ss-31-elamipretide-mitochondrial-guide\/\">SS-31 guide<\/a>. <\/p>\n<h2>\u4f5c\u7528\u30e1\u30ab\u30cb\u30ba\u30e0 \u2014 \u30ab\u30eb\u30b8\u30aa\u30ea\u30d4\u30f3\u3092\u6a19\u7684\u3068\u3057\u305f\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u5b89\u5b9a\u5316<\/h2>\n<p>SS-31&#8217;s mechanism is unique among peptides because its target is a phospholipid, not a receptor protein. Three interconnected effects define its pharmacology:<\/p>\n<ul>\n<li><strong>\u30ab\u30eb\u30b8\u30aa\u30ea\u30d4\u30f3\u7d50\u5408<\/strong> \u2014 SS-31\u306f\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u5185\u819c\u4e0a\u306e\u30ab\u30eb\u30b8\u30aa\u30ea\u30d4\u30f3\u306b\u9078\u629e\u7684\u306b\u7d50\u5408\u3057\u307e\u3059\u3002\u30ab\u30eb\u30b8\u30aa\u30ea\u30d4\u30f3\u306f\u3001\u307b\u307c\u3053\u306e\u90e8\u4f4d\u306b\u306e\u307f\u5b58\u5728\u3059\u308b\u7279\u5fb4\u7684\u306a\u8102\u8cea\u3067\u3042\u308a\u3001\u30af\u30ea\u30b9\u30c6\uff08\u96fb\u5b50\u4f1d\u9054\u7cfb\u8907\u5408\u4f53\u304c\u96c6\u307e\u308b\u6298\u308a\u7573\u307e\u308c\u305f\u5185\u819c\u8868\u9762\uff09\u306e\u69cb\u9020\u306b\u4e0d\u53ef\u6b20\u3067\u3059\u3002SS-31\u306e\u7d50\u5408\u306f <strong>\u30af\u30ea\u30b9\u30c6\u306e\u5f62\u614b\u3092\u5b89\u5b9a\u5316\u3055\u305b\u3001<\/strong> \u901a\u5e38\u3067\u3042\u308c\u3070\u30af\u30ea\u30b9\u30c6\u306e\u5d29\u58ca\u3084\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u6a5f\u80fd\u969c\u5bb3\u3092\u5f15\u304d\u8d77\u3053\u3059\u30b9\u30c8\u30ec\u30b9\u6642\u306b\u3002<\/li>\n<li><strong>ROS\u4f4e\u6e1b\u3068\u96fb\u5b50\u4f1d\u9054\u7cfb\u306e\u7dad\u6301<\/strong> \u2014 by preserving cristae architecture, SS-31 maintains the proper organization of electron-transport-chain complexes, preserving ATP synthesis and reducing electron &#8220;leakage&#8221; that generates reactive oxygen species. In ischemia-reperfusion study models, this translates to reduced oxidative damage and preserved mitochondrial function.<\/li>\n<li><strong>\u30c1\u30c8\u30af\u30ed\u30e0c\u653e\u51fa\u306e\u9632\u6b62<\/strong> \u2014 mitochondrial apoptosis begins with cytochrome c release from the inner membrane space into the cytoplasm. By preserving cristae structure, SS-31 preserves cytochrome c localization and blocks a critical apoptotic trigger. This is central to its cardiac ischemia-reperfusion signal.<\/li>\n<\/ul>\n<p>The practical studies implication: SS-31 is the reference mitochondria-targeted peptide. Where other peptides act at cell-surface receptors, SS-31 acts inside the organelle, preserving mitochondrial function in study models of metabolic stress, ischemia, and aging. <\/p>\n<h2>Published Evidence<\/h2>\n<p>SS-31 is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Primary mitochondrial disease studies<\/strong> \u2014 rare mitochondrial myopathy studies including Barth syndrome; SS-31 has FDA orphan-drug designation for this indication<\/li>\n<li><strong>Cardiac studies<\/strong> \u2014 heart failure, ischemia-reperfusion, cardiomyopathy, and cardiotoxicity rescue studies (Szeto, AAPS J 2014)<\/li>\n<li><strong>Renal studies<\/strong> \u2014 acute kidney injury, ischemia-reperfusion, and chronic kidney disease studies (Birk et al., J Am Soc Nephrol 2013)<\/li>\n<li><strong>Aging studies<\/strong> \u2014\u52a0\u9f62\u306b\u4f34\u3046\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u6a5f\u80fd\u969c\u5bb3\u3001\u9aa8\u683c\u7b4b\u306e\u8001\u5316\uff08\u30b5\u30eb\u30b3\u30da\u30cb\u30a2\uff09\u3001\u4e00\u822c\u7684\u306a\u7d30\u80de\u8001\u5316\u30de\u30fc\u30ab\u30fc<\/li>\n<li><strong>Neuroprotection studies<\/strong> \u2014 ischemic-stroke and neurodegeneration studies where mitochondrial dysfunction is a driver<\/li>\n<li><strong>Sarcopenia studies<\/strong> \u2014 skeletal-muscle mitochondrial function and age-related muscle loss studies<\/li>\n<li><strong>Comparative mitochondrial-agent studies<\/strong> \u2014 \uff5e\u3068\u4e26\u3079\u3066\u6bd4\u8f03 <a href=\"https:\/\/medsbase.com\/ja\/nad\/\">NAD+<\/a> (\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u88dc\u9175\u7d20) \u3068 MitoQ\uff08\u5225\u306e\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u6a19\u7684\u578b\u6297\u9178\u5316\u7269\u8cea\uff09\u3092\u7528\u3044\u305f\u30e1\u30ab\u30cb\u30ba\u30e0\u306e\u89e3\u660e<\/li>\n<\/ul>\n<p>For broader context on longevity and mitochondrial-compounds see the <a href=\"https:\/\/medsbase.com\/ja\/peptides\/\">\u30da\u30d7\u30c1\u30c9\u30ab\u30bf\u30ed\u30b0<\/a>. <\/p>\n<h2>\u5229\u7528\u53ef\u80fd\u306a\u529b\u4fa1\u3068\u6fc3\u5ea6<\/h2>\n<p>MedsBase\u306fSS-31\uff08\u30a8\u30e9\u30df\u30d7\u30ec\u30c1\u30c9\uff09\u3092\u4ee5\u4e0b\u306e\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u30b5\u30a4\u30ba\u3067\u5728\u5eab\u3057\u3066\u3044\u307e\u3059\uff1a<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u30d0\u30a4\u30a2\u30eb\u529b\u4fa1<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u4ee3\u8868\u7684\u306a\u4f7f\u7528\u4f8b<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u30d1\u30c3\u30af\u30b5\u30a4\u30ba<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, low-dose rodent work<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u300120\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, extended rodent studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u300120\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>50\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Large-scale studies, clinical-trial-matched doses (40 mg\/day), lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u300120\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The 50\u00a0mg vial size matches the clinical-trial 40 mg\/day dose used in Stealth BioTherapeutics&#8217;s human studies. Preclinical rodent studies typically uses smaller vials matched to 1\u20135 mg\/kg body weight. All strengths are supplied as lyophilized powder at 99%+ HPLC purity. <\/p>\n<h2>SS-31\u3068\u4ed6\u306e\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\/\u9577\u5bff\u5316\u5408\u7269\u306e\u6bd4\u8f03<\/h2>\n<p>SS-31 is part of a small but growing class of mitochondria-targeted studies agents. Key comparisons:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u8a55\u4fa1\u9805\u76ee<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">SS-31 (Elamipretide)<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">NAD+<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Epitalon<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u4e3b\u306a\u6a19\u7684<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u30ab\u30eb\u30b8\u30aa\u30ea\u30d4\u30f3\uff08\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u5185\u819c\u8102\u8cea\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u30b5\u30fc\u30c1\u30e5\u30a4\u30f3\u3001PARP\u9175\u7d20\u3001\u96fb\u5b50\u4f1d\u9054\u7cfb<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u907a\u4f1d\u5b50\u767a\u73fe\u3001\u677e\u679c\u4f53\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u4f5c\u7528\u6a5f\u5e8f\u306e\u8a3c\u62e0<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u5f37\u56fa\uff08\u8907\u6570\u306e\u7814\u7a76\u5ba4\u3001\u81e8\u5e8a\u8a66\u9a13\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u975e\u5e38\u306b\u5f37\u56fa\uff08\u5341\u5206\u306b\u7279\u6027\u89e3\u6790\u3055\u308c\u305f\u751f\u5316\u5b66\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u72ed\u7fa9\u306e\u30b0\u30eb\u30fc\u30d7\uff08\u30ab\u30f4\u30a3\u30f3\u30bd\u30f3\uff09<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u81e8\u5e8a\u72b6\u6cc1<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">FDA\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3001\u7b2c3\u76f8\u8a66\u9a13\uff08\u30d0\u30fc\u30b9\u75c7\u5019\u7fa4\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u672a\u627f\u8a8d\uff08\u9759\u8108\u5185\u6295\u4e0e\u3067\u306e\u4f7f\u7528\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u672a\u627f\u8a8d<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Strongest signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u5fc3\u7b4b\u865a\u8840\u3001\u814e\u75be\u60a3\u3001\u30b5\u30eb\u30b3\u30da\u30cb\u30a2<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u9577\u5bff\u3001\u30a8\u30cd\u30eb\u30ae\u30fc\u3001DNA\u4fee\u5fa9<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u30c6\u30ed\u30e1\u30a2\u3001\u6982\u65e5\u30ea\u30ba\u30e0<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u4e00\u822c\u7684\u306a\u7528\u91cf<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">5\uff5e40 mg\/\u65e5\uff08\u81e8\u5e8a\uff09\uff1b1\uff5e5 mg\/kg\uff08\u524d\u81e8\u5e8a\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">50\uff5e100 mg \u6bce\u65e5<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u76ae\u4e0b\u6ce8\u5c04\u30671\u65e55\uff5e10 mg<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>SS-31 is distinct because it is the only peptide targeting a mitochondrial lipid directly. Users often study it alongside <a href=\"https:\/\/medsbase.com\/ja\/nad\/\">NAD+<\/a> \uff08\u76f8\u88dc\u7684\u306a\u30b5\u30fc\u30c1\u30e5\u30a4\u30f3\u7d4c\u8def\u306e\u30ab\u30d0\u30ec\u30c3\u30b8\u306e\u305f\u3081\uff09\u304a\u3088\u3073 <a href=\"https:\/\/medsbase.com\/ja\/epitalon\/\">Epitalon<\/a> in multi-pathway longevity protocols. <\/p>\n<h2>\u4fdd\u7ba1\u65b9\u6cd5\u3068\u518d\u6eb6\u89e3<\/h2>\n<p><strong>\u518d\u6eb6\u89e3\u524d\uff1a<\/strong> \u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u306f\u5143\u306e\u5305\u88c5\u306e\u307e\u307e2\uff5e8\u00b0C\u3067\u51b7\u8535\u4fdd\u5b58\u3057\u3001\u6700\u957736\u30f6\u6708\u9593\u5b89\u5b9a\u3067\u3059\u3002\u7c89\u672b\u306e\u51cd\u7d50\u878d\u89e3\u30b5\u30a4\u30af\u30eb\u306f\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002 <strong>\u518d\u6eb6\u89e3\u624b\u9806\uff1a<\/strong> \u4e0a\u8a18\u306e\u8868\u306b\u5f93\u3044\u3001\u30da\u30d7\u30c1\u30c9\u30d0\u30a4\u30a2\u30eb\u306e\u5074\u58c1\u306b\u6cbf\u3063\u3066\u9759\u83cc\u6c34\u3092\u6ce8\u5165\u3057\u307e\u3059\u3002\u9759\u304b\u306b\u65cb\u56de\u3055\u305b\u3066\u304f\u3060\u3055\u3044 \u2014 \u884c\u3046 <strong>\u3057\u307e\u305b\u3093<\/strong> \u632f\u3089\u305a\u306b\u3001\u5b8c\u5168\u306b\u6eb6\u89e3\u3059\u308b\u307e\u30675\uff5e10\u5206\u9593\u9759\u7f6e\u3057\u307e\u3059\u3002\u6eb6\u6db2\u306f\u6f84\u660e\u3067\u7121\u8272\u3067\u3042\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002 <strong>\u5b8c\u5168\u306b\u518d\u6eb6\u89e3\u3057\u305f\u6eb6\u6db2\u306f\u3001\u7121\u8272\u900f\u660e\u3067\u3042\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/strong> 2\uff5e8\u00b0C\u3067\u51b7\u8535\u4fdd\u5b58\u3057\u300130\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u518d\u69cb\u6210\u5f8c\u306f\u51cd\u7d50\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h2 id=\"faqs\">\u3088\u304f\u3042\u308b\u8cea\u554f<\/h2>\n<h3>What is SS-31 used for in studies?<\/h3>\n<p>SS-31 (Elamipretide) is used in studies investigating mitochondrial disease (including Barth syndrome), cardiac ischemia-reperfusion, heart failure, acute kidney injury, chronic kidney disease, age-related mitochondrial dysfunction, sarcopenia, and neuroprotection. It has FDA orphan-drug designation but is <strong>\u3057\u307e\u305b\u3093<\/strong> yet FDA-approved for therapeutic use. Sold here strictly for clinical studies use only. <\/p>\n<h3>How is SS-31 different from other peptides?<\/h3>\n<p>SS-31\u304c\u72ec\u7279\u3067\u3042\u308b\u7406\u7531\u306f\u3001\u305d\u306e\u6a19\u7684\u304c <strong>\u30ab\u30eb\u30b8\u30aa\u30ea\u30d4\u30f3<\/strong> \u2014 a phospholipid on the inner mitochondrial membrane \u2014 not a cell-surface receptor. It is cell-permeable and reaches the mitochondrial matrix to stabilize cristae architecture and preserve electron-transport-chain function. Virtually every other peptide binds receptors on the cell surface. <\/p>\n<h3>What is the typical SS-31 dose?<\/h3>\n<p>Stealth BioTherapeutics&#8217; clinical trials have used 40\u00a0mg SC daily. Preclinical rodent studies typically uses 1\u20135\u00a0mg\/kg body weight daily. A 10\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 5.0\u00a0mg\/mL \u2014 100 ticks on a U-100 syringe delivers 5\u00a0mg. <\/p>\n<h3>SS-31\u306fFDA\u627f\u8a8d\u3055\u308c\u3066\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>SS-31\uff08\u30a8\u30e9\u30df\u30d7\u30ec\u30c1\u30c9\uff09\u306f\u3001\u539f\u767a\u6027\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u30df\u30aa\u30d1\u30c1\u30fc\u306b\u5bfe\u3057\u3066FDA\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u304a\u308a\u3001Stealth BioTherapeutics\u793e\u306b\u3088\u308a\u5f8c\u671f\u81e8\u5e8a\u958b\u767a\u6bb5\u968e\u306b\u3042\u308a\u307e\u3059\u3002\u73fe\u5728\u306f <strong>\u3057\u307e\u305b\u3093<\/strong> yet fully FDA-approved. All SS-31 sold by specialist suppliers is for clinical investigation, not the clinical-trial therapeutic product. <\/p>\n<h3>\u300cSS-31\u300d\u306e\u7565\u8a9e\u306e\u610f\u5473\u306f\u4f55\u3067\u3059\u304b\uff1f<\/h3>\n<p>SS-31\u306f <strong>Szeto-Schiller compound 31<\/strong>, after the Cornell users Hazel Szeto and Peter Schiller who developed the SS-series of mitochondria-targeted peptides in the 1990s and 2000s. The &#8220;31&#8221; is simply the compound number in their synthesis series. The compound was later licensed to Stealth BioTherapeutics and renamed Elamipretide (and Bendavia) for clinical development. <\/p>\n<h3>SS-31\u306f\u3069\u306e\u3088\u3046\u306b\u4fdd\u7ba1\u3059\u308c\u3070\u3088\u3044\u3067\u3059\u304b\uff1f<\/h3>\n<p>\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\uff1a2\u301c8\u00b0C\u306e\u51b7\u8535\u5eab\u3067\u5143\u306e\u5305\u88c5\u306e\u307e\u307e\u3001\u6700\u957736\u30f6\u6708\u5b89\u5b9a\u3002\u6eb6\u89e3\u5f8c\u6eb6\u6db2\uff1a2\u301c8\u00b0C\u306e\u51b7\u8535\u5eab\u3067\u4fdd\u5b58\u3057\u300130\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3002\u6eb6\u89e3\u5f8c\u6eb6\u6db2\u306f\u51cd\u7d50\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h3>SS-31\u306f\u3069\u306e\u3088\u3046\u306b\u518d\u69cb\u6210\u3059\u308c\u3070\u3088\u3044\u3067\u3059\u304b\uff1f<\/h3>\n<p>\u4e0a\u8a18\u306e\u6eb6\u89e3\u65e9\u898b\u8868\u306b\u5f93\u3063\u3066\u304f\u3060\u3055\u3044\u3002\u30d0\u30a4\u30a2\u30eb\u306e\u5185\u58c1\u306b\u6ce8\u5c04\u7528\u9759\u83cc\u6c34\u3092\u6cbf\u308f\u305b\u3066\u6ce8\u5165\u3057\u3001\u9759\u304b\u306b\u5186\u3092\u63cf\u304f\u3088\u3046\u306b\u56de\u3057\u3001\u5b8c\u5168\u306b\u6eb6\u89e3\u3059\u308b\u307e\u30675\uff5e10\u5206\u9593\u7f6e\u304d\u307e\u3059\u3002\u7d76\u5bfe\u306b <strong>\u3057\u307e\u305b\u3093<\/strong> \u632f\u3089\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h3>Can SS-31 be stacked with NAD+ in studies?<\/h3>\n<p>Yes \u2014 this is a common multi-pathway mitochondrial studies combination. SS-31 stabilizes cristae architecture and cardiolipin-dependent ETC function; <a href=\"https:\/\/medsbase.com\/ja\/nad\/\">NAD+<\/a> \u96fb\u5b50\u4f1d\u9054\u7cfb\u304a\u3088\u3073\u4e0b\u6d41\u306e\u30b5\u30fc\u30c1\u30e5\u30a4\u30f3\/PARP\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054\u306e\u88dc\u9175\u7d20\u57fa\u8cea\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u30e1\u30ab\u30cb\u30ba\u30e0\u306f\u76f8\u88dc\u7684\u3067\u3042\u308a\u3001\u91cd\u8907\u3057\u307e\u305b\u3093\u3002 <\/p>\n<h3>MedsBase\u3067\u306f\u3069\u306e\u5bb9\u91cf\u306e\u30ec\u30bf\u30eb\u30c8\u30eb\u30c1\u30c9\u3092\u53d6\u308a\u63c3\u3048\u3066\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>MedsBase carries SS-31 (Elamipretide) in 5\u00a0mg, 10\u00a0mg, and 50\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis on request. <\/p>\n<h3>Does SS-31 cause side reported effects?<\/h3>\n<p>Published preclinical and clinical-trial has reported a favorable safety profile. Most commonly reported effects in the clinical-trial literature are injection-site reactions. Because SS-31 has been studied in multiple human trials (Phase 2 and Phase 3), its safety profile is better-characterised than most peptides. <\/p>\n<h3>SS-31\u306fBendavia\u3084\u30a8\u30e9\u30df\u30d7\u30ec\u30c1\u30c9\u3068\u540c\u3058\u3067\u3059\u304b\uff1f<\/h3>\n<p>\u306f\u3044\u3002\u540c\u3058\u5316\u5408\u7269\u306b\u306f3\u3064\u306e\u540d\u79f0\u304c\u3042\u308a\u307e\u3059\uff1a <strong>SS-31<\/strong> (original Szeto-Schiller studies designation), <strong>Bendavia<\/strong> \uff08Stealth BioTherapeutics\u306e\u521d\u671f\u958b\u767a\u540d\uff09\u3001\u304a\u3088\u3073 <strong>Elamipretide<\/strong> (international nonproprietary name \/ INN). Studies literature uses SS-31 predominantly; clinical-trial literature uses Elamipretide or Bendavia. <\/p>\n<h3>SS-31\u306e\u534a\u6e1b\u671f\u306f\u3069\u306e\u304f\u3089\u3044\u3067\u3059\u304b\uff1f<\/h3>\n<p>SS-31\uff08\u30a8\u30e9\u30df\u30d7\u30ec\u30c1\u30c9\uff09\u306f\u3001\u76ae\u4e0b\u6295\u4e0e\u5f8c\u306e\u8840\u6f3f\u4e2d\u534a\u6e1b\u671f\u304c\u7d0430\uff5e60\u5206\u3068\u77ed\u3044\u3067\u3059\u304c\u3001\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u5185\u819c\u306e\u30ab\u30eb\u30b8\u30aa\u30ea\u30d4\u30f3\u306b\u5bfe\u3059\u308b\u89aa\u548c\u6027\u306b\u3088\u308a\u3001\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u3078\u306e\u84c4\u7a4d\u304c\u6301\u7d9a\u3057\u307e\u3059\u3002\u5fc3\u7b4b\u3084\u9aa8\u683c\u7b4b\u306a\u3069\u306e\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u304c\u8c4a\u5bcc\u306a\u81d3\u5668\u306b\u304a\u3051\u308b\u7d44\u7e54\u534a\u6e1b\u671f\u306f\u3001\u8840\u6f3f\u30af\u30ea\u30a2\u30e9\u30f3\u30b9\u3092\u8d85\u3048\u3066\u6570\u6642\u9593\u3068\u63a8\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002 <\/p>\n<h3>SS-31\u306f\u3069\u306e\u3088\u3046\u306b\u3057\u3066\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u3092\u7279\u7570\u7684\u306b\u6a19\u7684\u3068\u3059\u308b\u306e\u3067\u3059\u304b\uff1f<\/h3>\n<p>SS-31\u306f\u3001\u82b3\u9999\u65cf-\u30ab\u30c1\u30aa\u30f3\u6027\u306e\u4ea4\u4e92\u69cb\u9020\u3092\u6301\u3064Szeto-Schiller\u30da\u30d7\u30c1\u30c9\u3067\u3059\uff08D-Arg-\u30b8\u30e1\u30c1\u30eb-Tyr-Lys-Phe-NH\u2082\uff09\u3002\u3053\u306e\u914d\u5217\u306b\u3088\u308a\u3001\u7d30\u80de\u8cea\u30ec\u30d9\u30eb\u306e\u7d041,000\u500d\u3082\u306e\u6fc3\u5ea6\u3067\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u5185\u819c\u306b\u84c4\u7a4d\u3055\u308c\u307e\u3059\u3002\u3053\u308c\u306f\u3001\u8ca0\u306b\u5e2f\u96fb\u3057\u305f\u30ab\u30eb\u30b8\u30aa\u30ea\u30d4\u30f3\u30ea\u30f3\u8102\u8cea\u3078\u306e\u9759\u96fb\u7684\u5f15\u529b\u306b\u3088\u3063\u3066\u5a92\u4ecb\u3055\u308c\u307e\u3059\u3002\u30ab\u30eb\u30b8\u30aa\u30ea\u30d4\u30f3\u3078\u306e\u7d50\u5408\u306b\u3088\u308a\u3001\u96fb\u5b50\u4f1d\u9054\u7cfb\u8907\u5408\u4f53\u304c\u5b89\u5b9a\u5316\u3057\u3001\u6d3b\u6027\u9178\u7d20\u7a2e\uff08ROS\uff09\u306e\u7523\u751f\u304c\u6e1b\u5c11\u3057\u307e\u3059\u3002 <\/p>\n<h3>SS-31\u3092\u56fd\u969b\u914d\u9001\u3067\u6ce8\u6587\u3067\u304d\u307e\u3059\u304b\uff1f<\/h3>\n<p>Yes. MedsBase ships SS-31 worldwide from our dedicated peptide shipping network. Peptide-only orders qualify for our standalone peptide shipping service. Orders ship in temperature-controlled packaging with full tracking. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/ja\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/ja\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragment \u2014 soft tissue and vascular recovery<\/li>\n<li><a href=\"\/ja\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 \u9078\u629e\u7684\u30b0\u30ec\u30ea\u30f3\u4f5c\u52d5\u85ac \u2014 \u30b3\u30eb\u30c1\u30be\u30fc\u30eb\uff0f\u30d7\u30ed\u30e9\u30af\u30c1\u30f3\u3092\u4f34\u308f\u306a\u3044\u30af\u30ea\u30fc\u30f3\u306aGH\u30d1\u30eb\u30b9<\/li>\n<li><a href=\"\/ja\/cjc-1295-with-dac\/\"><strong>CJC-1295 with DAC<\/strong><\/a> \u2014 \u534a\u6e1b\u671f\u5ef6\u9577\u578bGHRH\u30a2\u30ca\u30ed\u30b0<\/li>\n<li><a href=\"\/ja\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>\u53c2\u8003\u6587\u732e<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">\u30a8\u30d3\u30c7\u30f3\u30b9\u306b\u57fa\u3065\u304f\u5b8c\u5168\u30ac\u30a4\u30c9\u3092\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a href=\"https:\/\/medsbase.com\/ja\/ss-31-elamipretide-mitochondrial-guide\/\"><strong>SS-31 (Elamipretide) \u2014 cardiolipin targeting, mitochondrial studies &amp; clinical trials<\/strong><\/a>. Covers Szeto-Schiller mechanism studies, Stealth BioTherapeutics clinical development, cardiac\/renal\/neurological applications, and realistic context.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705\u7d30\u80de\u30a8\u30cd\u30eb\u30ae\u30fc\u3092\u5411\u4e0a<br \/>\n\u2705\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u6a5f\u80fd\u3092\u30b5\u30dd\u30fc\u30c8<br \/>\n\u2705 \u9178\u5316\u30b9\u30c8\u30ec\u30b9\u3092\u8efd\u6e1b<br \/>\n\u2705 \u7d44\u7e54\u56de\u5fa9\u529b\u306e\u5411\u4e0a<br \/>\n\u2705 \u4ee3\u8b1d\u52b9\u7387\u306e\u4fc3\u9032<\/p>\n<p><strong>SS-31<\/strong> \u5408\u6210\u30da\u30d7\u30c1\u30c9\u5316\u5408\u7269\u3092\u542b\u307f\u307e\u3059\u3002<\/p>","protected":false},"featured_media":70982,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5476,5475],"class_list":["post-69029","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-elamipretide","product_tag-ss-31","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product\/69029","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/comments?post=69029"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media\/70982"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media?parent=69029"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_brand?post=69029"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_cat?post=69029"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_tag?post=69029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}